HZHai-Jun Zhang

Hai-Jun Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hai-Jun Zhang has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Bo Zhang

    State Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences

    1 shared publication
  • Chao Yang

    Department of Andrology, the Center for Men's Health, Urologic Medical Center, Shanghai Key Laboratory of Reproductive Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China

    1 shared publication
  • Deng-Yan Bai

    Department of Orthopedics, Gansu Second People's Hospital, Lanzhou, P.R. China

    1 shared publication
  • Hao Luo

    Department of Pathology, School of Basic Medical Sciences, Shandong Second Medical University, Weifang, China

    1 shared publication
  • Jian-Jun Shao

    Department of Orthopedics, Gansu Second People's Hospital, Lanzhou, P.R. China

    1 shared publication
  • Tao Zhu

    Department of Orthopedics, Gansu Second People's Hospital, Lanzhou, P.R. China

    1 shared publication

Latest Publications

  • Sinomenine can promote the proliferation and differentiation of osteoblasts by regulating the Akt/Runx2 signaling pathway in MC3T3-E1 cells

    by Bo Zhang, Haijun Zhang, Hao Luo, Chao Yang, Yi Yuan

    This study aimed to explore the effect of sinomenine on the proliferation and differentiation of MC3T3-E1 cells and the related mechanism. Mouse preosteoblastic cell line MC3T3-E1 cells were divided into four groups: control group, treatment of sinomenine with the concentrations of 100, 500 or 1000 μM. The proliferation and apoptosis of the cells were determined by MTT assay at 0, 24, 48 and 72 h, and flow cytometry method was used to determine the effect of sinomenine on the apoptosis of MC3T3-E1 cells at 72 h; furthermore, after 72 h, the cell culture supernatants were collected, and the levels of alkaline phosphatase and osteocalcin were examined by enzyme-linked immunosorbent assay (ELISA); next, cells were collected, and the expression of type I collagen (COL1A1), osteopontin (OPN), protein kinase B (Akt), runt-related transcription factor 2 (Runx2), B-cell lymphoma 2 (Bcl-2) and Bcl-2-associated X protein (Bax) were examined by RT-qPCR and Western Blot methods. It was observed that treatment of 500 and 1000 μM sinomenine has induced significant increase in the proliferation and decrease in the apoptosis of MC3T3-E1 cells; furthermore, sinomenine also lead to increased secretion of osteocalcin and alkaline phosphatase in MC3T3-E1 cells; finally, sinomenine induced marked increase in the expression of type I collagen, osteopontin and also induced the activation of the Akt/Runx2 signaling pathway. To sum up, we observed that sinomenine may promote the proliferation and differentiation of MC3T3-E1 cells via activating the Akt/Runx2 signaling pathway.


  • Unstable shoes for the treatment of lower back pain: a meta-analysis of randomized controlled trials

    by Deng-Yan Bai, Zhi-Guo Yuan, Jian-Jun Shao, Tao Zhu, Hai-Jun Zhang

    Objective: We aimed to perform a systematic review and meta-analysis to compare the treatment effects of unstable shoes and flat shoes on lower back pain patients. Data sources: Literature databases, including PubMed, Web of Science, and EMBASE (up to June 2019), were searched systematically. Review methods: Two authors independently screened the retrieved records and identified the randomized controlled trials where patients with lower back pain who wore unstable shoes as intervention and wore flat shoes as a control. Relevant data were extracted for meta-analysis using Review Manager 5.3 software. The Grading of Recommendations Assessment, Development and Evaluation approach was used to assess the pooled outcome evidence levels. Results: Five randomized controlled trials and 251 patients were included in the analysis. The meta-analysis results showed that there was a tendency toward a reduction in the Roland–Morris disability questionnaire score (mean difference (MD) –2.16, 95% confidence interval (CI) –4.28 to −0.03, I2 = 53%) and pain score (MD −0.84, 95% CI −1.66 to −0.02, I2 = 84%) in patients wearing unstable shoes compared to those wearing flat shoes. There was no significant difference in the life quality scores between the unstable shoe and flat shoe groups (MD −0.59, 95% CI −6.18 to 5.01, I2 = 0%). Functional disability and pain scores were determined to have very low-quality evidence, and life quality scores were determined to have low-quality evidence according to the Grading of Recommendations Assessment, Development and Evaluation analysis. Conclusion: Unstable shoes may be effective in treating lower back pain in the clinic, but the conclusion was limited by the current low-quality studies.